Search Results - "Acute Hepatic Porphyrias"

Acute hepatic porphyria - classification, diagnosis and treatment by Aleksandra Czekaj, Kinga Ruszel, Robert Dubel, Julia Dubel, Natalia Namroży

Connect to this object online.

Eslicarbazepine acetate is porphyrogenic and should be used with caution in patients with the acute hepatic porphyrias by Christopher D. Ma, Herbert L. Bonkovsky

Connect to this object online.

Spotlight on Givosiran as a Treatment Option for Adults with Acute Hepatic Porphyria: Design, Development, and Place in Therapy by Majeed CN, Ma CD, Xiao T, Rudnick S, Bonkovsky HL

Connect to this object online.

Pharmacokinetic‐pharmacodynamic model of urinary δ‐aminolevulinic acid reduction after givosiran treatment in patients with acute hepatic porphyria by Jongtae Lee, Megan Melch, Gabriel J. Robbie

Connect to this object online.

Preclinical Development of a Subcutaneous ALAS1 RNAi Therapeutic for Treatment of Hepatic Porphyrias Using Circulating RNA Quantification by Amy Chan, Abigail Liebow, Makiko Yasuda, Lin Gan, Tim Racie, Martin Maier, Satya Kuchimanchi, Don Foster, Stuart Milstein, Klaus Charisse, Alfica Sehgal, Muthiah Manoharan, Rachel Meyers, Kevin Fitzgerald, Amy Simon, Robert J Desnick, William Querbes

Connect to this object online.

Assessment of porphyrogenicity of drugs and chemicals in selected hepatic cell culture models through a fluorescence‐based screening assay by Christopher D. Ma, Cynthia G. Van Horn, Meimei Wan, Colin Bishop, Herbert L. Bonkovsky

Connect to this object online.